Molecular Cancer · 2012 · 56 citations · 24 references
Life SciencesCell BiologyOncologyCell SignalingMetastasisSignal TransductionCancer Cell SignalingInflammatory SignalingMetastatic Breast CancerMetastatic Signaling PathwaysTumor InvasionExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingInvasion-metastasis CascadeLuciferase Reporter AssaysLymph Node Metastasis PrognosisMalignant Breast TumorsTnm Staging SystemWestern Blotting
BACKGROUND: Patients with invasive breast ductal carcinoma (IBDC) with metastasis have a very poor prognosis. Little is known about the synergistic action of growth and inflammatory factors in IBDC metastases. METHODS: The expression of activated extracellular signal-regulated kinase1/2 (phosphorylated or p-ERK1/2) was analyzed by immunohistochemistry in IBDC tissue samples from 80 cases. BT474 IBDC cell migration and invasion were quantified using the Transwell assay. Matrix metalloproteinase (MMP)-9 expression and activity were analyzed by RT-PCR, Western blotting and zymography. Activator protein (AP)-1 activity was measured with a luciferase reporter gene assay. The Wilcoxon signed-rank test, Chi-square test, the partition of Chi-square test, independent t-test, and Spearman's method were used for the statistical analysis. RESULTS: Phosphorylated ERK1/2 was detected in 58/80 (72.5%) IBDC tissues, and was associated with higher TNM stage and lymph node metastasis, but not patient age or tumor size. Individually, epidermal growth factor (EGF), and interleukin (IL)-1β activated ERK1/2, increased cell migration and invasion, MMP-9 expression and activity, AP-1 activation in vitro and the expression of p-ERK1/2 was positively correlated with EGF expression levels, as well as IL-1β, MMP-9 and c-fos in IBDC tissue samples. Co-stimulation with EGF and IL-1β synergistically increased ERK1/2 and AP-1 activation, cell migration and invasion, and MMP-9 expression and activity. Inhibition of ERK1/2 using U0126 or siRNA abolished EGF and/or IL-1β-induced cell migration and invasion in a dose-dependent manner. CONCLUSION: Activated ERK1/2 was associated with higher TNM stage and lymph node metastasis in IBDC. Both in vitro and in vivo studies indicated that ERK-1/2 activation may increase the metastatic ability of IBDC cells. Growth and inflammatory factors synergistically induced IBDC cell migration and invasion via ERK1/2 signaling, AP-1 activation and MMP-9 upregulation.
24
Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2008 · 10.2K citations · Full text
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
Hanna Fredholm, Sonja Eaker, Jan Frisell et al. · PLoS ONE · 2009 · 496 citations · Full text
Medicine, Cancer Biology, Oncology +15
Induction and expression of amphiregulin in human pancreatic cancer.
Matthias P. Ebert, Masaaki Yokoyama, M S Kobrin et al. · PubMed · 1994 · 158 citations